Roche Extends Tender Offer for Illumina | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today announced it has extended its tender offer to acquire all outstanding shares of Illumina.

The offer is now set to expire March 23 at 6 p.m. EST. It had been scheduled to expire at the end of the day Feb. 24.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.